Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Nuclear Medicine Market Size Analysis from 2022 to 2027
1.5.1 Global Nuclear Medicine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Nuclear Medicine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Nuclear Medicine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Nuclear Medicine Industry Impact
Chapter 2 Global Nuclear Medicine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine (Volume and Value) by Type
2.1.1 Global Nuclear Medicine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Nuclear Medicine Revenue and Market Share by Type (2016-2021)
2.2 Global Nuclear Medicine (Volume and Value) by Application
2.2.1 Global Nuclear Medicine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Nuclear Medicine Revenue and Market Share by Application (2016-2021)
2.3 Global Nuclear Medicine (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Nuclear Medicine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Nuclear Medicine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Nuclear Medicine Consumption by Regions (2016-2021)
4.2 North America Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Nuclear Medicine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Nuclear Medicine Market Analysis
5.1 North America Nuclear Medicine Consumption and Value Analysis
5.1.1 North America Nuclear Medicine Market Under COVID-19
5.2 North America Nuclear Medicine Consumption Volume by Types
5.3 North America Nuclear Medicine Consumption Structure by Application
5.4 North America Nuclear Medicine Consumption by Top Countries
5.4.1 United States Nuclear Medicine Consumption Volume from 2016 to 2021
5.4.2 Canada Nuclear Medicine Consumption Volume from 2016 to 2021
5.4.3 Mexico Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Nuclear Medicine Market Analysis
6.1 East Asia Nuclear Medicine Consumption and Value Analysis
6.1.1 East Asia Nuclear Medicine Market Under COVID-19
6.2 East Asia Nuclear Medicine Consumption Volume by Types
6.3 East Asia Nuclear Medicine Consumption Structure by Application
6.4 East Asia Nuclear Medicine Consumption by Top Countries
6.4.1 China Nuclear Medicine Consumption Volume from 2016 to 2021
6.4.2 Japan Nuclear Medicine Consumption Volume from 2016 to 2021
6.4.3 South Korea Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 7 Europe Nuclear Medicine Market Analysis
7.1 Europe Nuclear Medicine Consumption and Value Analysis
7.1.1 Europe Nuclear Medicine Market Under COVID-19
7.2 Europe Nuclear Medicine Consumption Volume by Types
7.3 Europe Nuclear Medicine Consumption Structure by Application
7.4 Europe Nuclear Medicine Consumption by Top Countries
7.4.1 Germany Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.2 UK Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.3 France Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.4 Italy Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.5 Russia Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.6 Spain Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Nuclear Medicine Consumption Volume from 2016 to 2021
7.4.9 Poland Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Nuclear Medicine Market Analysis
8.1 South Asia Nuclear Medicine Consumption and Value Analysis
8.1.1 South Asia Nuclear Medicine Market Under COVID-19
8.2 South Asia Nuclear Medicine Consumption Volume by Types
8.3 South Asia Nuclear Medicine Consumption Structure by Application
8.4 South Asia Nuclear Medicine Consumption by Top Countries
8.4.1 India Nuclear Medicine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Nuclear Medicine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Nuclear Medicine Market Analysis
9.1 Southeast Asia Nuclear Medicine Consumption and Value Analysis
9.1.1 Southeast Asia Nuclear Medicine Market Under COVID-19
9.2 Southeast Asia Nuclear Medicine Consumption Volume by Types
9.3 Southeast Asia Nuclear Medicine Consumption Structure by Application
9.4 Southeast Asia Nuclear Medicine Consumption by Top Countries
9.4.1 Indonesia Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.2 Thailand Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.3 Singapore Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.5 Philippines Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Nuclear Medicine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Nuclear Medicine Market Analysis
10.1 Middle East Nuclear Medicine Consumption and Value Analysis
10.1.1 Middle East Nuclear Medicine Market Under COVID-19
10.2 Middle East Nuclear Medicine Consumption Volume by Types
10.3 Middle East Nuclear Medicine Consumption Structure by Application
10.4 Middle East Nuclear Medicine Consumption by Top Countries
10.4.1 Turkey Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.3 Iran Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.5 Israel Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.6 Iraq Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.7 Qatar Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Nuclear Medicine Consumption Volume from 2016 to 2021
10.4.9 Oman Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 11 Africa Nuclear Medicine Market Analysis
11.1 Africa Nuclear Medicine Consumption and Value Analysis
11.1.1 Africa Nuclear Medicine Market Under COVID-19
11.2 Africa Nuclear Medicine Consumption Volume by Types
11.3 Africa Nuclear Medicine Consumption Structure by Application
11.4 Africa Nuclear Medicine Consumption by Top Countries
11.4.1 Nigeria Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.2 South Africa Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.3 Egypt Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.4 Algeria Nuclear Medicine Consumption Volume from 2016 to 2021
11.4.5 Morocco Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Nuclear Medicine Market Analysis
12.1 Oceania Nuclear Medicine Consumption and Value Analysis
12.2 Oceania Nuclear Medicine Consumption Volume by Types
12.3 Oceania Nuclear Medicine Consumption Structure by Application
12.4 Oceania Nuclear Medicine Consumption by Top Countries
12.4.1 Australia Nuclear Medicine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 13 South America Nuclear Medicine Market Analysis
13.1 South America Nuclear Medicine Consumption and Value Analysis
13.1.1 South America Nuclear Medicine Market Under COVID-19
13.2 South America Nuclear Medicine Consumption Volume by Types
13.3 South America Nuclear Medicine Consumption Structure by Application
13.4 South America Nuclear Medicine Consumption Volume by Major Countries
13.4.1 Brazil Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.2 Argentina Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.3 Columbia Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.4 Chile Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.6 Peru Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Nuclear Medicine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Nuclear Medicine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Nuclear Medicine Business
14.1 GE Healthcare
14.1.1 GE Healthcare Company Profile
14.1.2 GE Healthcare Nuclear Medicine Product Specification
14.1.3 GE Healthcare Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Jubilant Pharma
14.2.1 Jubilant Pharma Company Profile
14.2.2 Jubilant Pharma Nuclear Medicine Product Specification
14.2.3 Jubilant Pharma Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Lantheus Medical Imaging
14.3.1 Lantheus Medical Imaging Company Profile
14.3.2 Lantheus Medical Imaging Nuclear Medicine Product Specification
14.3.3 Lantheus Medical Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Bracco Imaging
14.4.1 Bracco Imaging Company Profile
14.4.2 Bracco Imaging Nuclear Medicine Product Specification
14.4.3 Bracco Imaging Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Nordion
14.5.1 Nordion Company Profile
14.5.2 Nordion Nuclear Medicine Product Specification
14.5.3 Nordion Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Mallinckrodt
14.6.1 Mallinckrodt Company Profile
14.6.2 Mallinckrodt Nuclear Medicine Product Specification
14.6.3 Mallinckrodt Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 SIEMENS
14.7.1 SIEMENS Company Profile
14.7.2 SIEMENS Nuclear Medicine Product Specification
14.7.3 SIEMENS Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Triad Isotopes
14.8.1 Triad Isotopes Company Profile
14.8.2 Triad Isotopes Nuclear Medicine Product Specification
14.8.3 Triad Isotopes Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Bayer
14.9.1 Bayer Company Profile
14.9.2 Bayer Nuclear Medicine Product Specification
14.9.3 Bayer Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Eli Lilly
14.10.1 Eli Lilly Company Profile
14.10.2 Eli Lilly Nuclear Medicine Product Specification
14.10.3 Eli Lilly Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 China Isotope & Radiation
14.11.1 China Isotope & Radiation Company Profile
14.11.2 China Isotope & Radiation Nuclear Medicine Product Specification
14.11.3 China Isotope & Radiation Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Dongcheng
14.12.1 Dongcheng Company Profile
14.12.2 Dongcheng Nuclear Medicine Product Specification
14.12.3 Dongcheng Nuclear Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Nuclear Medicine Market Forecast (2022-2027)
15.1 Global Nuclear Medicine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Nuclear Medicine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Nuclear Medicine Value and Growth Rate Forecast (2022-2027)
15.2 Global Nuclear Medicine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Nuclear Medicine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Nuclear Medicine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Nuclear Medicine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Nuclear Medicine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Nuclear Medicine Consumption Forecast by Type (2022-2027)
15.3.2 Global Nuclear Medicine Revenue Forecast by Type (2022-2027)
15.3.3 Global Nuclear Medicine Price Forecast by Type (2022-2027)
15.4 Global Nuclear Medicine Consumption Volume Forecast by Application (2022-2027)
15.5 Nuclear Medicine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
